Mylan CEO says company has no plans to lower price of EpiPens

Mylan CEO Heather Bresch takes her seat on Capitol Hill in Washington, Wednesday prior to testifying before the House Oversight Committee hearing on EpiPen price increases. Bresch defended the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.

Brownback asked to take school funding leadership role

Two members of the Kansas State Board of Education believe Gov. Sam Brownback needs to take an active leadership role in crafting of the state's next school finance funding formula. Board chairman Jim McNiece said Wednesday during the second day of the board's monthly meeting that he's heartened Brownback recently asked for input from Kansans by the end of November about what should be part of the next funding formula.

Texas to stop refugee aid as Obama plans more resettlements

Texas will stop helping the U.S. government provide aid and services to refugees, state officials said Wednesday, severing ties at a time when President Barack Obama has announced intentions to dramatically increase the number of resettlements in 2017. Kansas and New Jersey also have pulled out of the federally funded refugee resettlement program due to what Republicans have called security concerns.

UPDATE 1-U.S. Senate clears way for $1.15 bln arms sale to Saudi Arabia

The U.S. Senate cleared the way for a $1.15 billion sale of tanks and other military equipment to Saudi Arabia on Wednesday, defending a close U.S. ally in the Middle East recently subject to harsh criticism in Congress. The overwhelming vote stopped an effort led by Republican Senator Rand Paul and Democratic Senator Chris Murphy to block the sale over concerns including Saudi Arabia's role in the conflict in Yemen and worries that the sale might fuel an ongoing regional arms race.

Senate votes to back $1 billion weapons sale to Saudi Arabia

The Senate on Wednesday backed the Obama administration's plan to sell more than $1 billion worth of American-made tanks and other weapons to Saudi Arabia, soundly defeating a bid to derail the deal pushed by lawmakers critical of the kingdom's role in Yemen's civil war. Senators who supported the sale said the United States can't deny its Middle East allies the weapons they need to combat Islamic State extremists and check Iran's aggression in the region.

Bill Weld should leave Libertarian ticket and support Clinton

Journalist Carl Bernstein, one of America's leading investigative reporters and a longtime friend of Bill Weld, the former Republican governor of Massachusetts and current Libertarian nominee for vice president under former New Mexico Gov. Gary Johnson Bill Weld should leave Libertarian ticket and support Clinton Poll: Clinton has slim lead in Wisconsin NH poll: Clinton leads Trump by 9 MORE Hillary Rodham Clinton Bill Weld should leave Libertarian ticket and support Clinton Clinton camp fears debate moderators will 'lower the bar' for Trump Clinton: Police shootings need 'to become intolerable' MORE This is a fascinating idea, though it should be noted that shortly after Bernstein made the statement, Weld denied he would leave the ticket and called it "wishful thinking."

IRS Chief Tells House Panel He Does Not Deserve Impeachment

IRS Commissioner John Koskinen expressed regret to Congress on Wednesday for his agency's past mistreatment of tea party groups, but said he has cooperated with congressional investigators and does not deserve to be impeached. The IRS chief made the remarks at a House Judiciary Committee hearing on a drive by hard-line conservatives to oust Koskinen.

Highlights From Senate Hearing On Ag Consolidation

HIGHLIGHTS FROM SENATE HEARING ON AG CONSOLIDATION Sep. 21, 2016 AP reports: Top officials for Monsanto and Bayer defended their proposed $66 billion merger before skeptical senators on Tuesday, insisting that the deal would lead to greater investments in technology that could help American farmers. Monsanto, the American seed and weed-killer, and Bayer, the German medicine and farm-chemical maker, responded to concerns from Iowa Sen. Charles Grassley, the Republican chairman of the Senate Judiciary Committee.

Egyptian president says there’s ‘no doubt’ Trump would make a…

Egyptian president says there's 'no doubt' Trump would make a strong leader and cuts him slack on last year's Muslim ban idea after meeting with both presidential candidates Sisi said Trump he could back down from Muslim ban as he develops as a result of experience, reports and advice from experts Clinton also met with Ukrainian head Poroshenko,who says he invited both candidates but Trump, and Japanese Prime Minister Shinzo Abe Egyptian President Abdel Fattah el-Sisi is cutting Donald Trump some slack over a proposal he made last year to ban foreign Muslims from entering the United States. 'I don't want to be unfair to anyone here.

Crop science execs defend mergers; NC Senator cites regulation as driving deals

Top officials for Monsanto and Bayer defended their proposed $66 billion merger before skeptical senators on Tuesday, insisting that the deal would lead to greater investments in technology that could help American farmers. Monsanto, the American seed and weed-killer, and Bayer, the German medicine and farm-chemical maker, responded to concerns from Iowa Sen. Charles Grassley, the Republican chairman of the Senate Judiciary Committee.

‘Broad shoulders’ and ‘a presidential look’: The Trump campaign uses…

What do voters hear when Indiana Gov. Mike Pence, in interview after interview, praises his running mate Donald Trump's "broad shoulders"? What do they hear when Trump repeatedly criticizes Hillary Clinton for not looking presidential - "and you need a presidential look"? Or when he time and again calls into question her strength and stamina? Many people, to use one of Trump's favorite phrasings, hear an effort to raise questions about whether a woman can serve as president. "Could it be more obvious?" asked pollster Christine Matthews, who has studied women voters for years amid work on Republican political campaigns.

Mylan CEO set to defend EpiPen prices amid public outcry

The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. "Price and access exist in a balance, and we believe we have struck that balance," Heather Bresch says in prepared testimony released by the House Oversight and Government Reform Committee ahead of her Wednesday appearance before the panel.

A new prostitution scandal roils a Louisiana Senate race

For a state accustomed to explosive sex scandals, the one dominating a U.S. Senate race here simmered for a long time before boiling over into public view last week. In a new book, " Murder in the Bayou ," author Ethan Brown cites multiple anonymous sources who claim that Rep. Charles W. Boustany Jr., a top Republican candidate for the Senate race, had been the client of three prostitutes who were later murdered.

Peppered with questions, Wells Fargo CEO seemed taken aback

Facing bipartisan outrage from a Senate panel over accusations of employee misconduct, Well Fargo CEO John Stumpf appeared taken aback by the intensity of the verbal lashing. At a few points, he seemed flustered and stumbled a bit over his words.

Mylan CEO defends EpiPen prices

In this file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento Mylan CEO Heather Bresch is defending the cost for life-saving EpiPens and is offering no suggestion that there are plans to lower prices. Bresch's prepared testimony was released by the House Oversight and Government Reform Committee ahead of her Sept.